Literature DB >> 8424456

Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

R L Shoeman1, C Sachse, B Höner, E Mothes, M Kaufmann, P Traub.   

Abstract

HeLa cell actin was cleaved by human immunodeficiency virus type 1 protease when in its soluble, globular form (G-actin). No cleavage of the polymerized, filamentous form of actin (F-actin) was observed when examined by denaturing gel electrophoresis; however, electron microscopy revealed a low level of cleavage of F-actin. Immunoblotting of mouse skeletal and human pectoral muscle myofibrils treated in vitro with human immunodeficiency virus type 1 protease showed that myosin heavy chain, desmin, tropomyosin, and a fraction of the actin were all cleaved. Electron microscopy of these myofibrils demonstrated changes consistent with cleavage of these proteins: Z-lines were rapidly lost, the length of the A bands was shortened, and the thick filaments (myosin filaments) were often laterally frayed such that the structures disintegrated. Nonmuscle myosin heavy chains were also cleaved by this enzyme in vitro. These data demonstrate that this protease can cause alterations in muscle cell ultrastructure in vitro that may be of clinical relevance in infected individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424456      PMCID: PMC1886840     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases.

Authors:  M Wallin; J Deinum; L Goobar; U H Danielson
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

2.  Intermediate filament assembly and stability in vitro: effect and implications of the removal of head and tail domains of vimentin by the human immunodeficiency virus type 1 protease.

Authors:  R L Shoeman; E Mothes; C Kesselmeier; P Traub
Journal:  Cell Biol Int Rep       Date:  1990-07

3.  Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments.

Authors:  A H Kaplan; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 4.  Actin: protein structure and filament dynamics.

Authors:  M F Carlier
Journal:  J Biol Chem       Date:  1991-01-05       Impact factor: 5.157

5.  Polymerizing properties of pepstatin A.

Authors:  E Mothes; R L Shoeman; R R Schröder; P Traub
Journal:  J Struct Biol       Date:  1990 Oct-Dec       Impact factor: 2.867

6.  Isolation and characterization of actin from cultured BHK cells.

Authors:  A Koffer; M J Dickens
Journal:  J Muscle Res Cell Motil       Date:  1987-10       Impact factor: 2.698

7.  Modified oligopeptides designed to interact with the HIV-1 proteinase inhibit viral replication.

Authors:  B Grinde; O Hungnes; E Tjøtta
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

8.  Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.

Authors:  Y Rivière; V Blank; P Kourilsky; A Israël
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

9.  Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.

Authors:  A G Tomasselli; J O Hui; L Adams; J Chosay; D Lowery; B Greenberg; A Yem; M R Deibel; H Zürcher-Neely; R L Heinrikson
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

10.  Non-viral cellular substrates for human immunodeficiency virus type 1 protease.

Authors:  R L Shoeman; C Kesselmier; E Mothes; B Höner; P Traub
Journal:  FEBS Lett       Date:  1991-01-28       Impact factor: 4.124

View more
  13 in total

1.  Expression and maturation of human foamy virus Gag precursor polypeptides.

Authors:  M L Giron; S Colas; J Wybier; F Rozain; R Emanoil-Ravier
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

2.  Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells.

Authors:  R L Shoeman; C Hüttermann; R Hartig; P Traub
Journal:  Mol Biol Cell       Date:  2001-01       Impact factor: 4.138

3.  Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers.

Authors:  S J Arrigo; K Huffman
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

4.  Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.

Authors:  Nathan W Cummins; Amy M Sainski-Nguyen; Sekar Natesampillai; Fatma Aboulnasr; Scott Kaufmann; Andrew D Badley
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

5.  The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.

Authors:  Rachel Van Duyne; Irene Guendel; Kylene Kehn-Hall; Rebecca Easley; Zachary Klase; Chenglong Liu; Mary Young; Fatah Kashanchi
Journal:  AIDS Res Ther       Date:  2010-07-06       Impact factor: 2.250

6.  Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts.

Authors:  David R M Graham; Elena Chertova; Joanne M Hilburn; Larry O Arthur; James E K Hildreth
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.

Authors:  Yannick Beauséjour; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.

Authors:  Zilin Nie; Gary D Bren; Stacey R Vlahakis; Alicia Algeciras Schimnich; Jason M Brenchley; Sergey A Trushin; Sarah Warren; David J Schnepple; Colin M Kovacs; Mona R Loutfy; Daniel C Douek; Andrew D Badley
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

9.  Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy.

Authors:  Hailiu Yang; Joseph Nkeze; Richard Y Zhao
Journal:  Cell Biosci       Date:  2012-09-12       Impact factor: 7.133

10.  Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors.

Authors:  Maricarmen Vallejos; Jules Deforges; Terra-Dawn M Plank; Alejandro Letelier; Pablo Ramdohr; Christopher G Abraham; Fernando Valiente-Echeverría; Jeffrey S Kieft; Bruno Sargueil; Marcelo López-Lastra
Journal:  Nucleic Acids Res       Date:  2011-04-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.